Motilal Oswal Alternates sells 23.28 lakh Molbio shares for ₹306 crore
In short
A Motilal Oswal Alternates fund sold 23.28 lakh shares of Molbio Diagnostics. The shares were sold at an average price of ₹1,315.01 each, for about ₹306 crore.
This matters because it is a large stake sale in a private healthcare company. The reporting does not say who bought the shares or how much stake the fund still holds.
What the reporting says
Business Excellence Trust III, a fund of Motilal Oswal Alternates, sold 23.28 lakh shares of Goa-based Molbio Diagnostics at an average price of ₹1,315.01 a share. The reported transaction value was about ₹306 crore and the stake sale was described as over 2%. The excerpt does not state the buyer, the post-sale holding, or why the block deal happened.
Why it matters
Business Excellence Trust III, a fund of Motilal Oswal Alternates, sold 23.28 lakh shares of Goa-based Molbio Diagnostics at an average price of ₹1,315.01 apiece, according to the publisher summary. The reported deal value was about ₹306 crore and the sale was said to be over 2%. The excerpt does not identify the buyer or give the remaining stake, so the post-transaction ownership is unknown.